Evidence map›Paper›PMID 37160805›Full record

ArticleAnnals of surgical oncology2023

Significant Predictors of Postoperative Morbidity After Radical Resection of Retroperitoneal Sarcoma in a Tertiary Center.

Claudia Di Prata, Benjamin Renouf, Dimitri Tzanis, Toufik Bouhadiba, Sarah Watson, Sophie El Zein, Sylvie Helfre, Nayla Nicolas, Julie Perlbarg-Samson, Olivier Brenet and 1 more

Abstract read
PubMed Publisher
In one paragraph

Article in Annals of surgical oncology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
2.6field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 2 countries.

Claudia Di PrataDepartment of Surgical Oncology, Institute Curie, Paris, France.
Benjamin RenoufDepartment of Hospital Research Direction, Institute Curie, Paris, France.
Dimitri TzanisDepartment of Surgical Oncology, Institute Curie, Paris, France.
Toufik BouhadibaDepartment of Surgical Oncology, Institute Curie, Paris, France.
Sarah WatsonDepartment of Medical Oncology, Institute Curie, Paris, France.
Sophie El ZeinDepartment of Biopathology, Institute Curie, Paris, France.
Sylvie HelfreDepartment of Radiotherapy, Institute Curie, Paris, France.
Nayla NicolasDepartment of Radiology, Institute Curie, Paris, France.
Julie Perlbarg-SamsonDepartment of Medical Information, Institute Curie, Paris, France.
Olivier BrenetDepartment of Anesthesiology, Institute Curie, Paris, France.
Sylvie BonvalotDepartment of Surgical Oncology, Institute Curie, Paris, France. sylvie.bonvalot@curie.fr.
Institut Curie · FRUniversity of Padua · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe safety of multivisceral resection of retroperitoneal sarcoma is an issue. Previous reports have investigated its associations with the pattern of resection and factors recognized mostly per operatively.

methodsAll consecutive RPS resections from May 2015 to April 2022 were studied retrospectively with respect to adverse events. Two univariate and multivariate logistic regression analyses were performed to investigate the associations between severe adverse events and factors recognized pre- and per operatively. Associations of adverse events with overall survival (OS) and local recurrence (LR) were investigated.

resultsA total of 265 surgical interventions corresponding to 251 patients were recorded (38 RPS surgeries/year). Severe postoperative adverse events (Clavien-Dindo ≥ 3) occurred in 50 patients (18.9%), 15 (5.6%) patients underwent an iterative laparotomy, and 6 patients (2.3%) died within 90 days. On multivariate analysis including all parameters known preoperatively, male sex, performance status, dedifferentiated liposarcoma histology, and low serum albumin level were found to be significant predictors of major complications, whereas the timing of surgery and preoperative treatment were not. On univariate analysis including all per operative parameters, transfusion requirement, operative time, number of digestive anastomoses, and pancreas and/or major arterial resection were found to entail higher operative risk. On multivariate analysis, only transfusion requirement was significant. There was no impact of postoperative adverse events on OS or LR.

conclusionsThe recognition of preoperative parameters that impact safety could mitigate the extent of the surgery, specifically the resection of adherent organs not overtly invaded. For the best decision, this surgery should be performed in referral centers.

Indexed as

Retroperitoneal NeoplasmsSarcomaHumansMaleMorbidityNeoplasm Recurrence, LocalRetrospective Studies

Identifiers

PMID37160805
OpenAlexW4376108395

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.